Assessment of anti-factor Xa activity of heparin in binary parenteral nutrition admixtures for premature neonates

Ann Pharm Fr. 2015 Jul;73(4):277-80. doi: 10.1016/j.pharma.2015.03.004. Epub 2015 Apr 8.

Abstract

An in vitro study was carried out to determine the anti-Xa activity of heparin in binary parenteral nutrition (BPN) admixtures for premature neonates in our neonatal intensive care unit (NICU) after a 24-hour infusion, as well as to assess drug interaction with a 50% glucose solution. Two types of bags were prepared: (1) BPN admixtures (composition defined in the NICU) including sodium heparin at 77 UI/mL and (2) bags containing only G50% with sodium heparin at 193 UI/mL. The anti-Xa activity of heparin was measured in bags at T0, after the 24-hour infusion and in eluates at the outlet of the infusion line after 24hours, using a validated chromogenic anti-Xa method. Comparisons of the mean concentration observed with the theoretical value for anti-Xa activity were performed with the Student t-test. Mean values of anti-Xa activity do not differ significantly from the values expected for all conditions. We found a slight variation in anti-Xa activity when infused over 24hours for both types of bags, with and without in-line filtration, showing that heparin remains stable during this infusion period in both BPN admixtures and G50%.

Keywords: 50% glucose solution; Activité anti-facteur Xa; Anti-factor Xa activity; Binary parenteral nutrition; Héparine sodique; Neonates; Nouveau-nés; Nutrition parentérale binaire; Sodium heparin; Solution glucosée à 50 %.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticoagulants / pharmacology*
  • Blood Coagulation Tests
  • Factor Xa / metabolism*
  • Filtration
  • Food, Formulated / analysis*
  • Heparin / pharmacology*
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Intensive Care Units, Neonatal
  • Parenteral Nutrition*

Substances

  • Anticoagulants
  • Heparin
  • Factor Xa